MD - Benha University 2011
Research Training - Mayo Clinic, Rochester, MN 2012-2013
Internal Medicine Residency - University of Kansas Medical Center 2013-2016
Hematology/Oncology Fellowship - University of Kansas Medical Center 2016-2019
Bone marrow transplant and cellular therapy Fellowship - University of Kansas Medical Center 2019
Research Focus: Acute myeloid leukemia, blood and marrow transplantation, T cell immune suppression, Cell therapy, mitigating cell therapy toxicity.

PhD- Biotechnology and Bioinformatics (Microbiology), North-Eastern Hill University, Shillong, India, 2019

MS- Applied Microbiology, VIT University, Vellore, India, 2011

BS – Microbiology (Honors), University of Burdwan, India, 2009

Research Focus: I am working as a Research Associate at the University of Kansas Medical Center supporting investigators through the Biomarker Discovery Lab (BDL) and the Kansas Institute for Precision Medicine COBRE Biobanking and Biomarker Validation (BBV) Core.  My work utilizes advanced techniques for the isolation and various analyses of nucleic acids (DNA, RNA, miRNA, cfDNA, etc.) including expression and mutational analysis to help understand their role in cancer development and progression and in early detection of disease.  I am also working on spatial transcriptomic analysis for human and mouse tissue samples using the Nanostring GeoMx platform.  The research projects that I support through the BDL and BBV Core aim to identify potential early detection biomarkers and potential therapeutic targets to help reduce the overall mortality associated with cancer and other diseases.

BS - Human Anatomy, Bayero University, Kano- Nigeria, 2018.

Research Focus: My research is centered on the identification and characterization of specific microRNAs (miRNAs) derived from Extracellular vesicles (EVs) as potential biomarkers for the early detection of ovarian cancer.

Ph.D. – Molecular Microbiology (Zoology), University of Calcutta, Kolkata, India, 2015

MS – Zoology (Special-Genetics and Molecular Biology), University of Calcutta, Kolkata, India, 2010

BS – Zoology, University of Calcutta, Kolkata, India, 2008

Research Focus: My research focus is the identification of potential biomarkers for cancers and other diseases is explored through collaborative efforts with scientists and clinicians, leveraging cutting-edge genomics and transcriptomics technologies. Emphasis is placed on the discovery of exosome-based and nucleic acid-based biomarkers, with the goal of advancing novel approaches for prognosis and therapeutic intervention.

BS – Psychobiology, University of California – Los Angeles, CA 1999
CA - Biotechnology Engineering, University of California - Los Angeles, 2018
CA - Advanced Biosciences, University of California - Berkeley, 2020

Research Focus: My research is developing and utilizing extracellular vesicles for treatment and prognostication of lymphoma and leukemia.

Email: amitra2@kumc.edu

PhD:  Biochemistry (Reproductive Genetics), University of Calcutta (CU), India ,2014 

MS:  Human Genetics, Sri Ramachandra Medical College & Research Institute (University), India 2007 

BS:   Genetics, Biochemistry and Zoology, Bangalore University, India ,2005 

Research Focus:  My research goal is to identify potential biomarkers for various types of cancer. My work involves using GeoMx Digital Spatial Profiler (DSP) to analyze proteins and RNA transcripts in tumors and surrounding tissues. My research studies on Protein and RNA expression, including whole transcriptome level across the tumor and tumor microenvironment which can help to develop biomarkers for early identification and intervention in cases of potential diseases leading to a better chance of cure or survival for the patient.

Ph.D. Dr. Sc. hum Molecular Medicine - Minor subjects (human genetics and diagnostic neuropathology) – Heidelberg University, Germany 2021.

Msc. Molecular Medicine - Institute of tropical medicine and infectious diseases- (JKUAT-Kenya) 2014

Bsc. Medical microbiology - Jomo Kenyatta University (JKUAT-Kenya) 2011.

My research focus on development and validation of small extracellular vesicles (sEVs) based detection systems for cancer early detection and disease monitoring. I use muti-omics approaches (transcriptomic, proteomics and epigenetics). Moreover, we employ Microarrays analysis of sEvs along with immunoassays, immunoprecipitation, RNAseq, qPCR and imaging to identify and prioritize candidate sEVs exo-proteins or miRNAs for the cancer fingerprint that can differentiate specific type of cancer. Furthermore, tumor microbiome and germline mutations associated with risk of familial cancer will be screened. I hope to identify EV associated genetic changes, pathways, methylome-patterns, novel mRNA/miRNA and proteins that have greatest stability and producibility to diagnose and precisely track disease burden with initial focus on ovarian cancer.

Ph.D. - Biochemistry, Microbiology & Molecular Biology, Pennsylvania State University, 2006
BS - Biochemistry, Philadelphia College of Pharmacy and Science, 1998

Research Focus: Exploiting biological networks to improve clinical treatment of ovarian cancer; identification of biomarkers for the early detection and risk of breast and ovarian cancer.

Ph.D. – Biotechnology, Shoolini University of Biotechnology and Management Sciences, India 2017
MS – Biotechnology, Hemvati Nandan Bahuguna Gharwal University, India 2008
BS – Education – Himachal Pradesh University, India 2006
BS – Basic Sciences – Himacheal Pradesh University, India 2005

Research Focus: My research focuses on identification of potential biomarkers for cancers and other diseases in collaboration with other scientists and clinicians. Our studies aim to discover exosome based, and nucleic acid-based biomarkers which can open new horizons for prognosis and therapeutics

Ph.D. – Chemistry (Biological), Kansas State University – Manhattan, KS 2021
B.Tech – Biotechnology, Kathmandu University – Nepal 2015

Research Focus: I am interested in the multi-faceted avenues of EV research focusing on the role of EVs in cancer diagnosis and therapy, including biomarker development, imaging-based diagnosis, and therapy. Currently, my research aim is to identify extracellular vesicles (EVs)-based circulating biomarkers for the early detection of ovarian cancer. EVs play a significant role in disease progression including metastasis. My work will also involve tracking these EVs using imaging techniques to elucidate their role in the progression of ovarian cancer.

MA – Bioinformatics, New York University – New York, NY 2013
M.D. – Virginia Commonwealth University – Richmond, VA 2017
Obstetrics and Gynecology Residency, Virginia Tech Carilion Clinic – Roanoke, VA 2017-2021

Research Focus: Oncobiome, microbiome, tumor microenvironments, ovarian cancer microbiome, endometrial cancer microbiome, early detection strategies, targeted treatment strategies

Ph.D. - Cancer Biology, Health Sciences University of Hokkaido, Japan, 2022

B.D.S. - Bachelor of Dental Surgery, Bangladesh Dental College, University of Dhaka, 2013

Research focus: My research is centered on the identification and advancement of innovative therapeutic drug interventions for Ewing Sarcoma, the second most prevalent bone malignancy affecting children and young adults. In the course of my research, I aim to contribute to the development of new and effective treatments tailored to address this particular medical condition. My research will also include with a specific emphasis on the involvement of EVs (extracellular vesicles), in the processes of cancer diagnosis and therapy. This scrutiny encompasses aspects such as the advancement of biomarkers, diagnostic methodologies based on imaging, and therapeutic applications.

BS – Chemical Engineering with minors in Biomedical Engineering, Biology and Chemistry, University of Tulsa – Tulsa, OK 2019

Research Focus: Focused on determining the role of small Extracellular Vesicles (sEVs) in ovarian cancer niche formation and cancer invasion, with a particular emphasis on the tumorigenic properties of cancer sEVs on healthy Fallopian tissue. Other interests include identification of ovarian tumor derived sEV-based biomarkers for use in liquid biopsies and production of ovarian tumor organoids for use as novel in vitro models of cancer development and high throughput drug discovery in ovarian cancer.  

Ph.D. - Regulatory Biology, Cleveland State University/Cleveland Clinic Lerner Research Institute (OH), 2019
MS - Biotechnology, Osmania University (India), 2012
BS - Biochemistry, Microbiology and Chemistry, Osmania University (India), 2010

Research Focus: My research is focused on identification and development of novel therapeutic drug treatments for Ewing Sarcoma, the second most common bone malignancy in children and young adults.